Integris Medtech Limited
About Integris Medtech Limited
Data last updated:
Integris Medtech Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Evercure Holding Pte Ltd. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 25 April 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85110DL2008PLC177230. Its GSTIN is 07AABCI9779A2ZE (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹157 Cr and a paid-up capital of ₹10.83 Cr. It is led by directors including Rajani Kesari and Gurmit Singh Chugh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1st Floor Metro Tower Lsc M.O.R Land New Rajinder Nagar, New Delhi, Delhi, India – 110060.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,959.58 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹6.55 Cr (net margin -0.3%) and EBITDA of ₹65.75 Cr (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years and 57% over five years.
The company is associated with 1 brand: Translumina. As per MCA filings, the company has open charges of ₹268 Cr and satisfied charges of ₹4 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending. The company has 6 deals on record (2 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹498.28 Cr; the latest was in December 2024.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Integris Medtech has one previous CIN (Corporate Identification Number): U85110DL2008PTC177230. The current CIN is U85110DL2008PLC177230, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110DL2008PLC177230 | Current |
| U85110DL2008PTC177230 | Previous |
Contact details
Integris Medtech Limited's registered office is in New Delhi, Delhi.
- Registered Address1st Floor Metro Tower Lsc M.O.R Land New Rajinder Nagar, New Delhi, Delhi, India – 110060
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Integris Medtech operates one associated brand: Translumina. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of drug-eluting stents and cardiovascular devices. It produces drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories. The company operates advanced manufacturing facilities and is committed to delivering high-quality products. Its focus is on developing and providing innovative cardiovascular intervention technologies. The manufacturing processes adhere to rigorous international standards. | translumina.com |
Business activity
The main business activity of Integris Medtech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Integris Medtech Limited, buy the company report.
Financials of Integris Medtech Limited
FY 2024 filings availableIntegris Medtech Limited reported revenue of ₹1,959.58 Cr (up 239% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 239% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹65.75 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.55 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Integris Medtech Limited, buy the company report.
Board of directors and KMP of Integris Medtech Limited
Integris Medtech Limited currently reports 8 directors and 3 key managerial personnel. 11 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arjun Oberoi | Nominee Director | 21 Jul 2025 | 1 Years 3 Months | Current |
| Rajani Kesari Also directs: Translumina Therapeutics Private Limited, Sanofi India Limited, Thermax Limited. and 1 more | Director | 01 Aug 2025 | 1 Years 2 Months | Current |
| Hemant Sultania Also directs: Orophilos Advisers LLP, Samavesh Ventues and Advisory LLP, Nephrocare Health Services Limited and 4 more | Cfo | 25 Aug 2025 | 1 Years 2 Months | Current |
| Gurmit Singh Chugh Also directs: Pathway Medical LLP, Advance Therapeutics LLP, Halemed Medical Private Limited and 5 more | Director | 25 Apr 2008 | 18 Years 6 Months | Current |
| Darpan Batra | Company Secretary | 26 Sep 2025 | 1 Years 1 Months | Current |
| Annaswamy Vaidheesh Also directs: North Star Asia LLP, Universal Nutriscience Private Limited, Appasamy Associates Private Limited and 1 more | Director | 26 Aug 2025 | 1 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2025 | 101178028 | Hdfc Bank Limited | ₹60 Cr | Open | |
| 01 Oct 2025 | 101181836 | Hdfc Bank Limited | ₹17 Cr | Open | |
| 03 May 2023 | 100718116 | Hdfc Bank Limited | ₹140 Cr | Open | |
| 06 Mar 2023 | 100689281 | Others | ₹2 Cr | Open | |
| 02 Mar 2022 | 100547246 | Citi Bank N.A. | ₹17 Cr | Open |
To see the full charge records of Integris Medtech Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Integris Medtech Limited has 6 deals on record (2 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹498.28 Cr; the latest was in December 2024.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2024 | Funding round | ₹358.29 Cr | Investors: India SME Investments, Mission Street Pte Ltd, 2 individuals |
| Sep 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Everstone Capital Management |
| May 2023 | Funding round | ₹140 Cr | Investors: Everstone Capital Management, 2 individuals |
| Sep 2019 | Rights issue | ₹10 Cr | Investors: Everstone Capital Management, 2 individuals |
| May 2019 | Acquisition | ₹517.94 Cr | Buyer: Everstone Capital Management Seller: 2 individuals |
To see the full deal history of Integris Medtech Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Integris Medtech Limited has 2 court cases on record: 2 filed by Integris Medtech. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
| High courts | 1 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Government of NCT of Delhi Through the Office of Additional District Magistrate Collector of Stamps | Pending |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed by the company against M/S Medisis India | Pending |
To see the full case history of Integris Medtech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Integris Medtech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Integris Medtech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCI9779A2ZE | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Integris Medtech Limited, buy the company report.
Recent activity
Integris Medtech Limited has 22 board changes on record since 2008: 11 appointments and 11 cessations. The latest: Gurmit Singh Chugh ceased to be Director on 07 Oct 2025.
25 earlier events are in the company report.
Frequently asked questions
Integris Medtech is an active public limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 25 April 2008 (18+ years old) and is registered under CIN U85110DL2008PLC177230.
Integris Medtech has 11 current directors and KMP:
- Arjun Oberoi - Nominee Director
- Rajani Kesari - Director
- Gurmit Singh Chugh - Director
- Annaswamy Vaidheesh - Director
- Ramesh Subrahmanian - Director
- Avnish Mehra - Nominee Director
- Punita Sharma - Director
- Vishal Omprakash Goenka - Nominee Director
- Hemant Sultania - Cfo
- Darpan Batra - Company Secretary
- Probir Das - Ceo
The latest financial statements of Integris Medtech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Integris Medtech is 07AABCI9779A2ZE, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Integris Medtech is U85110DL2008PLC177230. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Integris Medtech has 2 court cases on record: 2 filed by the company. 2 are pending. Most are in the district courts.
Integris Medtech was incorporated on 25 April 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Integris Medtech has 6 deals on record (2 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹498.28 Cr; the latest was in December 2024.
Gurmit Singh Chugh ceased to be Director on 07 Oct 2025. Punita Sharma ceased to be Director on 07 Oct 2025. Darpan Batra was appointed as Company Secretary on 26 Sep 2025. Integris Medtech has 22 board changes on record in total.
The registered office of Integris Medtech is at 1st Floor Metro Tower Lsc M.O.R Land New Rajinder Nagar, New Delhi, Delhi, India – 110060.